Susan E Bronskill1,2,3,4, Michael A Campitelli1, Andrea Iaboni5,6, Nathan Herrmann4,6, Jun Guan1, Laura C Maclagan1, Jennifer Watt2,7, Paula A Rochon1,2,3,7, Andrew M Morris7, Lianne Jeffs2,8, Chaim M Bell1,7,9, Colleen J Maxwell1,10,11. 1. Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. 2. Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 3. Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada. 4. Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 5. Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada. 6. Departments of Psychiatry. 7. Medicine, University of Toronto, Toronto, Ontario, Canada. 8. Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada. 9. Divisions of General Internal Medicine and Infectious Diseases, Sinai Health System, Toronto, Ontario, Canada. 10. Schools of Pharmacy. 11. Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada.
Abstract
OBJECTIVES: To evaluate whether risk of fall-related injuries differs between nursing home (NH) residents newly dispensed low-dose trazodone and those newly dispensed benzodiazepines. DESIGN: Retrospective, matched cohort study in linked, population-based administrative data. Matching was based on propensity score ( ± 0.2 standard deviations of the score as a caliper), age ( ± 1 year), sex, frailty status, and history of dementia. The derived propensity score included demographic characteristics, clinical comorbidities, cognitive and functional status, and risk factors for falls. SETTING: All NHs in Ontario, Canada. PARTICIPANTS: Propensity score-matched pairs of residents aged 66 and older who received a full clinical assessment between April 1, 2010, and March 31, 2015 (N=7,791). MEASUREMENTS: Hospitalization (emergency department visit or acute care admission) for a fall-related injury within 90 days of exposure. Subdistribution hazard functions accounted for competing risk of death. Sensitivity analyses were used to examine falls resulting in hip or wrist fracture only, as well as different lengths of follow-up at 30, 60, and 180 days. RESULTS: Cumulative incidence of a fall-related injury in the 90 days after index was 5.7% for low-dose trazodone users and 6.0% for benzodiazepine users (between-group change=-0.29, 95% confidence interval (CI)=-1.02-0.44]; hazard ratio=0.94, 95% CI=0.83-1.08). Findings were consistent across sensitivity analyses. CONCLUSION: New use of low-dose trazodone was no safer with respect to a risk of a fall-related injury than new use of benzodiazepines. Additional studies to compare the effectiveness and risks of low-dose trazodone with those of a variety of psychotropic drug therapies are required in light of increasing trends in the use of trazodone in NHs.
OBJECTIVES: To evaluate whether risk of fall-related injuries differs between nursing home (NH) residents newly dispensed low-dose trazodone and those newly dispensed benzodiazepines. DESIGN: Retrospective, matched cohort study in linked, population-based administrative data. Matching was based on propensity score ( ± 0.2 standard deviations of the score as a caliper), age ( ± 1 year), sex, frailty status, and history of dementia. The derived propensity score included demographic characteristics, clinical comorbidities, cognitive and functional status, and risk factors for falls. SETTING: All NHs in Ontario, Canada. PARTICIPANTS: Propensity score-matched pairs of residents aged 66 and older who received a full clinical assessment between April 1, 2010, and March 31, 2015 (N=7,791). MEASUREMENTS: Hospitalization (emergency department visit or acute care admission) for a fall-related injury within 90 days of exposure. Subdistribution hazard functions accounted for competing risk of death. Sensitivity analyses were used to examine falls resulting in hip or wrist fracture only, as well as different lengths of follow-up at 30, 60, and 180 days. RESULTS: Cumulative incidence of a fall-related injury in the 90 days after index was 5.7% for low-dose trazodone users and 6.0% for benzodiazepine users (between-group change=-0.29, 95% confidence interval (CI)=-1.02-0.44]; hazard ratio=0.94, 95% CI=0.83-1.08). Findings were consistent across sensitivity analyses. CONCLUSION: New use of low-dose trazodone was no safer with respect to a risk of a fall-related injury than new use of benzodiazepines. Additional studies to compare the effectiveness and risks of low-dose trazodone with those of a variety of psychotropic drug therapies are required in light of increasing trends in the use of trazodone in NHs.
Authors: Emad Sidhom; John T O'Brien; Adrian J Butcher; Heather L Smith; Giovanna R Mallucci; Benjamin R Underwood Journal: Int J Mol Sci Date: 2022-02-11 Impact factor: 5.923
Authors: Anita Iacono; Michael A Campitelli; Susan E Bronskill; David B Hogan; Andrea Iaboni; Laura C Maclagan; Tara Gomes; Mina Tadrous; Charity Evans; Andrea Gruneir; Qi Guan; Thomas Hadjistavropoulos; Cecilia Cotton; Sudeep S Gill; Dallas P Seitz; Joanne Ho; Colleen J Maxwell Journal: Drugs Aging Date: 2022-08-17 Impact factor: 4.271
Authors: Michael A Campitelli; Susan E Bronskill; Laura C Maclagan; Daniel A Harris; Cecilia A Cotton; Mina Tadrous; Andrea Gruneir; David B Hogan; Colleen J Maxwell Journal: JAMA Netw Open Date: 2021-08-02
Authors: Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam Journal: Lancet Date: 2020-07-30 Impact factor: 79.321